Case ReportInternational Journal of Basic & Clinical Pharmacology

Publication:
Olanzapine induced hyperprolactinemia

Int J Basic Clin Pharmacol. 2013;2(6):836-837.DOI10.5455/2319-2003.ijbcp20131234

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Olanzapine, a second generation antipsychotic is widely used for the treatment of schizophrenia and bipolar disorders. Though olanzapine is an efficacious antipsychotic it has been associated with many adverse effects like weight gain, hyperlipidemia, diabetes mellitus, etc necessitating its discontinuation. Here, we present two cases of hyperprolactinemia induced by olanzapine.

Keywords

Affiliations

  1. Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
  2. Psychiatrist, Dr. A.V. Baliga Memorial Hospital, Udupi, Karnataka, India

Full item record